135 related articles for article (PubMed ID: 2010305)
1. Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review.
Buraggi GL; Gasparini M; Seregni E
Int J Rad Appl Instrum B; 1991; 18(1):45-50. PubMed ID: 2010305
[TBL] [Abstract][Full Text] [Related]
2. Pilot, multicenter and prospective trials with an anti-CEA antibody.
Buraggi GL; Gasparini M; Seregni E; Bombardieri E; Regalia E; Maffioli L
Int J Biol Markers; 1992; 7(3):189-92. PubMed ID: 1431344
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
4. Tumor imaging of colo-rectal carcinoma with an anti-CEA monoclonal antibody.
Gasparini M; Ripamonti M; Seregni E; Regalia E; Buraggi GL
Int J Cancer Suppl; 1988; 2():81-4. PubMed ID: 3162449
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
Bischof-Delaloye A; Delaloye B; Buchegger F; Gilgien W; Studer A; Curchod S; Givel JC; Mosimann F; Pettavel J; Mach JP
J Nucl Med; 1989 Oct; 30(10):1646-56. PubMed ID: 2795205
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
9. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
[TBL] [Abstract][Full Text] [Related]
10. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab')2.
Aprile C; Prati U; Saponaro R; Roveda L; Carena M; Gastaldo L
Int J Rad Appl Instrum B; 1991; 18(1):51-2. PubMed ID: 2010306
[TBL] [Abstract][Full Text] [Related]
13. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy of colorectal carcinomas and recurrences with a technetium-99m-labeled monoclonal anti-CEA-antibody (MAB XBW 431/26).
Lind P
J Nucl Med; 1990 Apr; 31(4):535-6. PubMed ID: 2157833
[No Abstract] [Full Text] [Related]
15. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
[TBL] [Abstract][Full Text] [Related]
16. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
[TBL] [Abstract][Full Text] [Related]
17. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibodies].
Murayama H; Watanabe T; Sakamoto J; Tadokoro M; Takagi H; Sakuma S
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1732-41. PubMed ID: 2594001
[TBL] [Abstract][Full Text] [Related]
18. The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method.
Hölting T; Schlag P; Steinbächer M; Kretzschmar U; Georgi P; Herfarth C
Cancer; 1989 Aug; 64(4):830-3. PubMed ID: 2743277
[TBL] [Abstract][Full Text] [Related]
19. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
[TBL] [Abstract][Full Text] [Related]
20. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.
Lamki LM; Patt YZ; Murray JL
Cancer Treat Res; 1990; 51():293-312. PubMed ID: 1977451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
